Skip to main content
SpringerLink
Log in

Biomodulation in Head and Neck Carcinomas: Therapeutic Approaches in Europe

  • Chapter
Novel Approaches to Selective Treatments of Human Solid Tumors

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 339))

  • 120 Accesses

Abstract

Biomodulation, especially in head and neck carcinomas (H & N Ca.)/ refers to both cytotoxic drugs and ionizing radiations activities. Due to the heterogeneity of the tumor cells, modulation would address just as well to hypoxic cells as to therapeutically induced resistant cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. T.H. Loeffler, J. Lindemann, H. Luckhaupt et al.,Chemotherapy of Advanced and Relapsed Squamous Cell Cancer of the Head and Neck with Split-dose Cisplatinui, 5-Fluorouracil and Leucovorin, Adv.Exp.Med.BioL 244: 269 (1988).

    Google Scholar 

  2. A. Caty, J. Lefebvre, X. Mirabel et al., Induction Chemotherapy by a Combination of 5-FU-Cisplatinum-Folinic Acid in Advanced Head and Neck Squamous Cell arcinoma, Pro.ASCO 11 Abst.793(1992).

    Google Scholar 

  3. H. Guaraldi, A. Martoni, A, Tononi et al., 5-Fluorouracil + Folinic Acid with Cisplatinum and Bleomycin in the Treatment of Advanced Head and Neck Squamous Cell Carcinoma, Ann. Onc. 2: 379 (1991).

    CAS  Google Scholar 

  4. A, Bensmaine, E. Tellez-Bernai, T. Guillot et al., Chimiothérapie Néoadjuvante par CDDP, 5-FU, Acide Folinique et Vindésine (Perfusion Continue) dans les Carcinomes ORL localement avancés, Bull. Cancer 79: 558 (1992).

    Google Scholar 

  5. A. Dreyfuss, J.R Clark, J.E. Wright et al., Continuous Infusion High-Dose Leucovorin with 5-Fluorouracil and Cisplatin for Untreated Stage IV Carcinoma of the Head and Neck, Ann. Int. Med. 112: 167 (1990).

    PubMed  CAS  Google Scholar 

  6. E.E. Vokes, R.L. Schilsky, R.R. Weichselbaum et al., Induction Chemotherapy with Cisplatin, Fluorouracil and High-Dose Leucovorin for Locally Advanced Head and Neck Cancer: A Clinical and Pharmacologic Analysis, J. Clin. Oncol. 8: 241 (1990).

    PubMed  CAS  Google Scholar 

  7. G. Fountzilas, J. Daniilidis, K.S. Sridhar et al., Induction Chemotherapy with a New Regimen Alternating Cisplatin, Fluorouracil with Mitomycin, Hydroxyurea and Bleomycin in Carcinomas of Nasopharynx or Other Sites of the Head and Neck Region, Cancer 66: 1453 (1990).

    Article  PubMed  CAS  Google Scholar 

  8. G. Fountzilas, P. Kosmidis, P. Makrentonakis et al., Carboplatin Continuous Infusion 5- Fluoro uracil and Mid-Cycle High-Dose Methotrexate as Initial Treatment in Patients with Locally Advanced Head and Neck Cancer, Tumori 77: 426 (1991).

    PubMed  CAS  Google Scholar 

  9. H. Boussen, E. Cvitkovic, J.L. Wendung et al., Chemotherapy of Metatstatic and/or Recurrent Undifferenciated Nasopharyngeal Carcinoma with Cisplatin, Bleomycin and Fluorouracil, J.Clin. Oncol. 9: 1675 (1991).

    CAS  Google Scholar 

  10. G. Forni, M. Giovarelli, A. Santoni, A Lymphokine-Activated Tumor Inhibition in vivo. The Local Administration of Interleukin-2 Triggers Nonreactive Lymphocytes from Tumor-bearing Mice to Inhibit Tumor Growth, J.Immunol. 134: 1305 (1985).

    PubMed  CAS  Google Scholar 

  11. G. Forni, H. Fujiwara, F. Martino et al., Helper Strategy in Tumor Immunology: Expansion of Helper Lymphocytes and Utilization of Helper Lymphokines for Experimental and Clinical Immunotherapy, Cancer Met. Rev. 7: 289 (1988).

    CAS  Google Scholar 

  12. G. Cortesina, A. de Stefani, M. Giovarelli et al., Treatment Recurrent Squamous Cell Carcinoma of the Head and Neck with Low Doses of Interleukin-2 Injected Perilymphatically, Cancer 62: 2482 (1988).

    Article  PubMed  CAS  Google Scholar 

  13. G. Cortesina, A. de Stefani, E. Galeazzi et al., The Effect of Preoperative Local Interleukin-2(IL-2) Injections in Patients with Head and Neck Squamous Call Carcinoma, Acta Oto-Lar. 111: 428 (1991).

    Article  CAS  Google Scholar 

  14. G. Cortesina, A. De Stefani, E. Galeazzi et al., Interleukin-2 Injected around Tumor-Draining Lymph Nodes in Head and Neck Cancer, Head-Neck 13 /2: 125 (1991).

    Article  PubMed  CAS  Google Scholar 

  15. M. Squadrelli-Saraceno, L. Rivoltini, G. Cantu et al., Local Adoptive Immunotherapy of Advanced Head and Neck Tumors with Lak Cell and Interleukine-2, Tumori 76: 566 (1990).

    PubMed  CAS  Google Scholar 

  16. V. Mattijssen, P. H. De Mulder, J. H. Schornagel et al., Clinical and Immunopathological Results of a Phase II Study of Perilymphatically Injected Recombinant Interleukin-2 Locally for Advanced, Nonpretreated Head and Neck Squamous Cell Carcinoma, J. Iim. 10: 63 (1991).

    CAS  Google Scholar 

  17. P. Musiani, E. De Campora, S. Valitutti, Effect of Low Doses of Interleukin-2 Injected Perilymphatically and Peritumorally in Patients with Advanced Primary Head and Neck Squamous Cell Carcinoma, J. Biol. Resp. Mod 8: 571 (1989).

    CAS  Google Scholar 

  18. P.J. Cohen, M.T. Lotze, J.R. Roberts et al., The Immunopathology of Sequential Tumor Biopsies in Patients Treated with Interleukin-2, Am. J. Pathol. 129: 208 (1987).

    PubMed  CAS  Google Scholar 

  19. G. Melioli, G. Margarino, M. Scala et al., Perilymphatic Injections of Recombinant Interleukin-2 (rIL-2) Partially Correct the Immunologic defects in Patients with Advanced Head and Neck Squamous Cell Carcinoma, Laryngo. 102 /5: 572 (1992).

    Article  CAS  Google Scholar 

  20. S. Toma, M. Benasso, M. Merlano et al., Concomittant Cisplatin and Recombinant Interferon alpha-2b in Head and Neck Cancer, Drug Invest. 3: 341 (1991).

    Article  Google Scholar 

  21. A. Bensmaine, N. Azli, F. Janot et al., Etude de la faisabilité de l’Association 5-FU-CDDP-Interféron (IFN alpha 2b) dans les Récidives et/ou Métastases des Carcinomes Epidermoides de la Tête et du Cou, Bull. Cancer 79: 559 (1992).

    Google Scholar 

  22. E.E. Vokes, M.J. Ratain, R. Mick et al., A Clinical Pharmacologie Phase I-II Study of PFL with Interferon alpha-2b (IFN) for Head and Neck Cancer (HNC), Pro.ASCO 11 Abst. 782 (1992).

    Google Scholar 

  23. M.E. Gore, P. Riches, K.A. MacLennan et al., Intra-Arterial Interleukin-2 in Squamous Cell Carcinoma of the Head and Neck, Pro. ASCO 11 Abst. 814 (1992).

    Google Scholar 

  24. B. Fiorentino, C. Amatetti, P. di Stefano et al., Weekly Sequential Administration of Interferon-alpha-2b (IFNa-2b) and Interleukin-2 (IL-2) in Patients with Advanced Malignancies, Pro. ASCO. 11 Abst. 835 (1992).

    Google Scholar 

  25. F. Geara, T.A. Girinski, N. Chavaudra et al., Estimation of Clonogenic Cell Fraction in Primary Culture Derived from Human Squamous Cell Carcinomas, Int. J. Rad. Oncol. Biol. Phys. 21: 661 (1991).

    Article  CAS  Google Scholar 

  26. J.F. Fowler, The Phantom of Tumor Treatment-Continually Rapid Proliferation Unmasked, Rad.Oncol 22: 156 (1991).

    Article  CAS  Google Scholar 

  27. J.F. Fowler, Apparent Rates of Proliferation of Acutely Responding Normal Tissues during Radiotherapy of Head and Neck Cancer, Int. J. Rad. Oncol. Biol. Phys. 21: 1451 (1991).

    Article  CAS  Google Scholar 

  28. S.M. Bentzen, H.D. Thames, Clinical Evidence for Tumor Clonogen Regeneration: Interpretations of the Data, Rad.Oncol. 22: 161 (1991).

    Article  CAS  Google Scholar 

  29. K.R. Trott, J. Kummermehr, Accelerated Repopulation in Tumours and Normal Tissues, Rad. Oncol. 22: 159 (1991).

    CAS  Google Scholar 

  30. G. Sanguinetti, R. Corvo, E. Accomando et al., Accelerated Hyperfractionated (Concomitant Boost) Radiotherapy for Head and Neck Carcinomas: Preliminary Results, 3rd Int. Conf. on H & N Ca., San Francisco, California (July 26–30 1992 ).

    Google Scholar 

  31. S.H. Bentzen, L.V Johansen, J, Overgaard et al., Clinical Radiobiology of Squamous Cell Carcinoma of the Oropharynx, Int. J. Rad. Oncol. Biol. Phys. 20: 1197 (1991).

    Article  CAS  Google Scholar 

  32. G. Wiernick, C.J. Alcock, T.D. Bates et al., Final Report on the Second British Institute of Radiology Fractionation Study: Short versus Long overall Treatment Times for Radiotherapy of Carcinoma of the Laryngo-Pharynx, Br. J. Radiol. 64: 232 (1991).

    Article  Google Scholar 

  33. J.C. Horiot et al., Hyperfractionated compared with Conventional Radiotherapy in Oropharyngeal Carcinoma: an EORTC Randomized Trial, Int. J. Radiat. Oncol. Biol. Phys. 26: 779 (1990).

    CAS  Google Scholar 

  34. L.H. Pinto, P.C.V. Canary, C.H.H. Araujo et al., Prospective Randomized Trial Comparing Hyperfractionated versus Conventional Radiotherapy in Stages III and IV Oropharyngeal Carcinoma, Int. J. Rad. Oncol. Biol. Phys. 21: 557 (1991).

    Article  CAS  Google Scholar 

  35. F. Sanchiz, A. Milla, J. Torner et al., Single Fraction per Day versus Two Fractions per Day versus Radiochemotherapy in the Treatment of Head and Neck Cancer, Int. J. Rad. Oncol. Biol. Phys. 19: 1347 (1990).

    Article  CAS  Google Scholar 

  36. A.C. Begg, I. Hofland, M. Van Glabbeke et al., Predictive Value of Potential Doubling Time for Radiotherapy of Head and Neck Tumor Patients: Results from the EORTC Cooperative Trial 22851, Sem. Radiat.Oncol. 2: 1 (1992).

    Google Scholar 

  37. E. Geido, W. Giaretti, R. Corvo et al., Cell Kinetics by in vivo Bromodeoxyuridine and Flow Cytometry for the Radiotherapy Planning of Head and Neck Tumors, 3rd Int.Conf. on H & N Ca., San Francisco, California (July 26–30 1992 ).

    Google Scholar 

  38. M.I. Saunders, S. Dische, E.J. Grosch et al., Experience with CHART, Int. J. Radiat. Oncol. Phys. 21: 871 (1991).

    Article  CAS  Google Scholar 

  39. J. Overgaard, H. Sand, A.P. Andersenet ah, Misonidazole Combined with Split-course Radiotherapy in the Treatment of Invasive Carcinoma of Larynx and Pharynx. Report from the DAHANCA 2 Study, Int. J. Radiat. Oncol. Biol. Phys. 16: 1065 (1989).

    Article  PubMed  CAS  Google Scholar 

  40. C.N. Coleman, L. Noll, N.Riese et al., Final Report of the Phase I Trial of Continuous Infusion Etanizadole (SR 2508): a Radiation Therapy Oncology Group Study, Int. J. Radiat. Oncol. Biol. Phys. 22: 577 (1992).

    Article  PubMed  CAS  Google Scholar 

  41. D. Chassagne, I. Charreau, H. Sancho-Garnier et al., First Analysis on Tumor Regression for the European Randomized Trial of Etanizadole Combined with Radiotherapy in Head and Neck Carcinomas, Int. J. Radiat. Oncol. Biol. Phys. 22: 581 (1992).

    Article  PubMed  CAS  Google Scholar 

  42. J. Overgaard, H. Sand-Hassen, B. Lindelov et al., Nimorazole as a Hypoxic Radiosensitizer in the Treatment of Supraglottic, Larynx and Pharynx Carcinoma. First Report from the DAHANCA protocol 5–85, Radiother. Oncol. 20: 143 (1990).

    Google Scholar 

  43. D.J. Honess, N.M. Bleehen, Effects of Calcium Channel Blockers on Renal Function in Mice, Int. J. Radiat. Oncol. Biol. Phys. 22: 443 (1992).

    Article  PubMed  CAS  Google Scholar 

  44. M.R. Horsman, P.E.G. Kristjansen, M. Mizuno et al., Biochemical and Physiological Changes Induced by Nicotinamide in a C3H Mouse Mammary Carcinoma and CDF1 Mice, Int. J. Radiat. Oncol. Biol. Phys. 22: 451 (1992).

    Article  PubMed  CAS  Google Scholar 

  45. K. Skov, S. MacPhail, Interaction of Platinum Drugs with Clinically Relevant X-Ray Doses in Mammalian Cells: a Comparison of Cisplatin, Carboplatin, Iproplatin and Tetraplatin, Int. J. Radiat. Oncol. Biol. Phys. 20: 221 (1991).

    Article  PubMed  CAS  Google Scholar 

  46. P. Lamblin, P. Scalliet, B. Coster et al., Influence of Cisplatinum on Intestinal Tolerance to Photon and Neutron Irradiation in Mice, (to be published 1992 ).

    Google Scholar 

  47. J.M. Bachaud, J.M. David, G. Boussin et al., Combined Postoperative Radiotherapy and Weekly Cisplatin Infusion for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Preliminary Report of a Randomized Trial, Int. J. Radiat. Biol. Phys. 20: 243 (1991).

    Article  CAS  Google Scholar 

  48. M. Busch, E. Dühmke, Longtime Impact of Low Dose Cisplatinum and Accelerated Fractionation of Radiotherapy of Head and Neck Cancer, Pro; ASCO. 11 Abst. 789 (1992).

    Google Scholar 

  49. P. Volling, S. Starr, Carboplatin Plus Radiation Therapy in Head and Neck Cancer, Sem. Oncol. 18: 17 (1991).

    CAS  Google Scholar 

  50. M. Airoldi, V. Brando, G. Cortesina et al., Simultaneous Radiation Therapy (RT) and Chemotherapy (CT) with Carboplatin (CBDCA) for Locally Unresectable Stage III-IV Head and Neck Cancer (HNC), Pro. ASCO. 11 Abst. 805 (1992).

    Google Scholar 

  51. R. Orecchia, G.L. Sannazzari, M. Airoldi et al., Daily Carboplatin (CBDCA) and Standard Radiation Therapy (RT) in Inoperable Head and Neck Cancer (HNC): a Dose-Finding Study, Pro. ASCO. 11 Abst. 795 (1992).

    Google Scholar 

  52. A. Testolin, F. Pozza, F. Bagatella et al., Combined Treatment for Locally Advanced Carcinoma of Head and Neck. Preliminary Results of a Randomized Trial: Cisplatin (CP) vs Carboplatin (CBP) and Concomittant Radiotherapy (RT), Pro. ASCO. 11 Abst. 794 (1992).

    Google Scholar 

  53. T.C. Lo, A.L. Wiley, F.J. Ansfield, Combined Radiation Therapy and 5-Fluorouracil for Advanced Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: a Randomized Study, Am. J. Roentgenol. 126: 229 (1976).

    CAS  Google Scholar 

  54. T.S. Lawrence, D.K. Heimburger, D.S. Shewach, The Effects of Leucovorin and Dipyridamole on Fluoropyrimidine-Induced Radiosensitization, Int. J. Radiat. Oncol. Biol. Phys. 20: 377 (1991).

    Article  PubMed  CAS  Google Scholar 

  55. K.J. Scanlon, H. Kashani-Sabet, Elevated Expression of Thymidylate Synthase Cycle Genes in Cisplatin-Resistant Human Ovarian Carcinoma A2780 Cells, Proc. Natl. Acad. Sci. USA 85: 650 (1988).

    Article  PubMed  CAS  Google Scholar 

  56. J. Eskandari, H. de Muizon, D. Bonnet et al., 5-Fluorouracil-Leucovorin and Concomittant Radiotherapy in Advanced Head and Neck Carcinomas: a Phase I Study, Pro. ASCO. 11 Abst. 791 (1992).

    Google Scholar 

  57. W. Dobrowsky, E. Dobrowsky, H. Strassl et al., Response to Preoperative Concomittant Radio-chemotherapy with Mitomycin C and 5-Fluorouracil in Advanced Head and Neck Cancer, Eur. J. Cancer. Clin. Oncol. 25: 845 (1989).

    Article  PubMed  CAS  Google Scholar 

  58. D. Gandia, P. Wibault, P. Harandas, Radiochimiothérapie Simultanée (RS) dans les récidives Locorégionales des Cancers Epidermoïdes de la Tête et du Cou (CETC), Bull. Cancer 79: 558 (1992).

    Google Scholar 

  59. M. Merlano, M. Benasso, H. Cavallari et al., Combined Chemotherapy and Radiation Therapy in Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck, Cancer 67: 915 (1991).

    Article  PubMed  CAS  Google Scholar 

  60. T.G. Wendt, R.C. Hartenstein, T.P.U. Wustrow, Cisplatin, Fluorouracil with Leucovorin Calcium Enhancement, and Synchronous Accelerated Radiotherapy in the Management of Locally Advanced Head and Neck Cancer: a Phase I Study, J. Clin. Oncol. 7: 471 (1989).

    PubMed  CAS  Google Scholar 

  61. M.J. Evans, C.J. Kovacs, J.M. Gooya et al., Interleukin-I alpha Protects against the Toxicity Associated with Combined Radiation and Drug Therapy, Int. J. Radiat. Oncol. Biol. Phys. 20: 303 (1991).

    Article  PubMed  CAS  Google Scholar 

  62. C.J. Kovacs, J.M. Gooya, J.P. Harrell et al., Altered Radioprotective Properties of Interleukin I alpha (IL-1) in Non-Hematologic Tumor-Bearing Animals, Int. J. Radiat. Oncol. Biol. Phys. 20: 307 (1991).

    Article  PubMed  CAS  Google Scholar 

  63. G.J. Peters, C.L. van der Wilt, F. Gyergyay et al., Protection by WR-2721 of the Toxicity Induced by the Combination of Cisplatin and 5-Fluorouracil, Int. J. Radiat. Oncol. Biol. Phys. 22: 785 (1992).

    Article  PubMed  CAS  Google Scholar 

  64. J.F. Ensley, J.R. Jacobs, A. Weaver et al., The Correlation between Response to Cisplatinura Combination Chemotherapy and Subsequent Radiotherapy in Previously Untreated Patients with Advanced Squamous Cells Cancers or the Head and Neck, Cancer 54: 811 (1984).

    Article  PubMed  CAS  Google Scholar 

  65. C.M.J. De Pooter, P.G. Scalliet, H.J. Elst et al., Resistance Patterns between Cisdi-amminedichloroplatinum(II) and Ionizing Radiation, Cancer Research 51: 4523 (1991).

    PubMed  Google Scholar 

  66. W.C.M. Dempke, L.K. Hosking, B.T, Hill, Expression of Collateral Sensitivity to Cisplatin, Methotrexate, and Fluorouracil in a Human Ovarian Carcinoma Cell Line Following Exposure Fractionated X-Irradiation in vitro, Sem. Oncol. 19: 66 (1992).

    CAS  Google Scholar 

  67. C. Jaulerry, J. Rodriguez, F. Brunin et al., Induction Chemotherapy in Advanced Head and Neck Tumors: Results of two Randomized Trials, Int. J. Radiat. Oncol. Biol. Phys. 23: 483 (1992).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Oncology, Marseille, France

    Jan Eskandari

Authors
  1. Jan Eskandari
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, New York, USA

    Youcef M. Rustum

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Eskandari, J. (1993). Biomodulation in Head and Neck Carcinomas: Therapeutic Approaches in Europe. In: Rustum, Y.M. (eds) Novel Approaches to Selective Treatments of Human Solid Tumors. Advances in Experimental Medicine and Biology, vol 339. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2488-5_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2488-5_21

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6060-5

  • Online ISBN: 978-1-4615-2488-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation